vimarsana.com

Page 20 - Seng Index Technical Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

S&P 500, Hang Seng Weekly Open: Vaccine Rollout and Stimulus Buoy Sentiment

S&P 500, Hang Seng Weekly Open: Vaccine Rollout and Stimulus Buoy Sentiment S&P 500, HANG SENG, ASIA-PACIFIC MARKET OUTLOOK: Asia-Pacific markets kicked off the week with an upbeat tone, “range-bound” conditions set to continue Brexit talks deadline extended, offering temporary relief to investors despite little progress Traders await the FOMC meeting and a string of central bank interest rate decisions later this week Advertisement Brexit, Vaccines, Central Banks, Asia-Pacific Stocks Weekly Outlook: Asia-Pacific stocks kicked off the week with a upbeat tone after the EU and the UK agreed to extend the Brexit talks deadline. The FDA has approved Pfizer’s vaccine for emergency use. US equity futures opened around half a percent higher, leading the Nikkei 225, ASX 200 and Hang Seng Index to trade higher.

Nasdaq 100 Falls Most In a Month, Nikkei 225 and Hang Seng May Drop

Nasdaq 100 Falls Most In a Month, Nikkei 225 and Hang Seng May Drop NASDAQ 100, NIKKEI 225, HANG SENG INDEX OUTLOOK: APAC stocks retreated, tech shares dragged the Wall Street benchmarks lower US stimulus talks faced deadlock over a business liability shield and aid to state and local governments The US Dollar strengthened, risking further pullback in risk assets and metals. ECB meeting in focus Advertisement Tech Pullback, US Relief Package, ECB Interest Rate Decision, Asia-Pacific at Open: The Nasdaq 100 index tumbled 2.1% overnight as stalling US stimulus talks and a seemingly smooth rollout of coronavirus vaccines encouraged profit-taking activity in the tech sector. The Dow Jones and S&P 500 index registered relatively small losses, both falling from their record highs. The negotiation between Republicans and Democrats over the fiscal bill faced deadlock over a business liability shield and aid to state and local governments. Traders are perhaps taking this opportunity to

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.